Joseph Harding Selected Research

terizidone

4/2021	Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis.
10/2020	Population Pharmacokinetics of Cycloserine and Pharmacokinetic/Pharmacodynamic Target Attainment in Multidrug-Resistant Tuberculosis Patients Dosed with Terizidone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joseph Harding Research Topics

Disease

4	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2022 - 10/2020
2	Body Weight (Weight, Body) 01/2021 - 02/2010
2	Tuberculosis (Tuberculoses) 01/2021 - 10/2020
1	Psychotic Disorders (Schizoaffective Disorder) 04/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 04/2021
1	Opioid-Related Disorders (Opiate Addiction) 11/2019
1	Human Influenza (Influenza) 02/2010

Drug/Important Bio-Agent (IBA)

2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2022 - 01/2021
2	terizidoneIBA 04/2021 - 10/2020
2	Cycloserine (Seromycin)FDA Link 04/2021 - 10/2020
2	Pharmaceutical PreparationsIBA 01/2021 - 10/2020
1	Pyridoxine (Pyridoxin)FDA LinkGeneric 04/2021
1	Ethionamide (Trecator-SC)FDA Link 01/2021
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2021
1	Messenger RNA (mRNA)IBA 02/2010
1	CytokinesIBA 02/2010
1	Proteins (Proteins, Gene)FDA Link 02/2010
1	Viral AntigensIBA 02/2010
1	salicylhydroxamic acid (SHAM)IBA 02/2010

Therapy/Procedure

1	Aftercare (After-Treatment) 10/2020
1	Drug Therapy (Chemotherapy) 11/2019